Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Sponsor content
352 result(s) found, displaying 281 to 290
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Prescription medicine registrationActive ingredients: pembrolizumab (rch).
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/500 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/500 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 100/1000 sitagliptin(as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DIFICID fidaxomicin 200 mg tablets in bottles.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pembrolizumab (rch)